Global Nucleic Acid Therapeutics Contract Manufacturing Market Size & Outlook
Global nucleic acid therapeutics contract manufacturing market, 2021-2033 (US$M)
Related Markets
Global nucleic acid therapeutics contract manufacturing market highlights
- The global nucleic acid therapeutics contract manufacturing market generated a revenue of USD 9,848.8 million in 2024 and is expected to reach USD 33,839.6 million by 2033.
- The market is expected to grow at a CAGR (2025 - 2033) of 15.1% by 2033.
- In terms of segment, rna-based therapies accounted for a revenue of USD 7,138.9 million in 2024.
- Gene Therapy is the most lucrative type segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, China is expected to register the highest CAGR from 2025 to 2033.
Global data book summary
| Market revenue in 2024 | USD 9,848.8 million |
| Market revenue in 2033 | USD 33,839.6 million |
| Growth rate | 15.1% (CAGR from 2025 to 2033) |
| Largest segment | Rna-based therapies |
| Fastest growing segment | Gene Therapy |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Gene Therapy, RNA-based Therapies |
Other key industry trends
- In terms of revenue, the North America accounted for 47.4% of the global nucleic acid therapeutics contract manufacturing market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2033.
- By country, China is the fastest growing regional market and is projected to reach USD 1,815.2 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Nucleic Acid Therapeutics Contract Manufacturing Market Scope
Nucleic Acid Therapeutics Contract Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Avecia | View profile | 501-1000 | Milford, Massachusetts, United States, North America | http://www.avecia.com |
| BioSpring Gesellschaft für Biotechnologie mBH | View profile | 501-1000 | Frankfurt, Hessen, Germany, Europe | http://www.biospring.de |
| Ajinomoto Bio-Pharma Services | View profile | 1001-5000 | San Diego, California, United States, North America | https://ajibio-pharma.com |
| BioCina | View profile | 101-250 | Thebarton, South Australia, Australia, Oceania | https://www.biocina.com/ |
| CordenPharma | View profile | 5001-10000 | Plankstadt, Baden-Wurttemberg, Germany, Europe | http://cordenpharma.com |
| Bachem Holding AG | View profile | 2006 | Hauptstrasse 144, Bubendorf, Switzerland, 4416 | https://www.bachem.com |
| AGC Biologics | View profile | 1001-5000 | Bothell, Washington, United States, North America | http://www.agcbio.com/ |
| Kaneka Corp | View profile | 13284 | 3-2-4, Nakanoshima, Kita-ku, Osaka, Japan, 530-8288 | http://www.kaneka.co.jp |
| Catalent Inc | View profile | 17219 | 14 Schoolhouse Road, Somerset, NJ, United States, 08873 | https://www.catalent.com |
| Wuxi AppTec Co Ltd | View profile | 41116 | 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, China, People's Republic of, 200131 | https://www.wuxiapptec.com |
| Eurofins Scientific SE | View profile | 61798 | 23 Val Fleuri, Luxembourg, Luxembourg, L-1526 | https://www.eurofins.com |
| Agilent Technologies Inc | View profile | 17700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | https://www.agilent.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Lonza Group Ltd | View profile | 18000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | https://www.lonza.com |
Global nucleic acid therapeutics contract manufacturing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to nucleic acid therapeutics contract manufacturing market will help companies and investors design strategic landscapes.
Rna-based therapies was the largest segment with a revenue share of 72.48% in 2024. Horizon Databook has segmented the Global nucleic acid therapeutics contract manufacturing market based on gene therapy, rna-based therapies covering the revenue growth of each sub-segment from 2021 to 2033.
- Global Nucleic Acid Therapeutics Contract Manufacturing Type Outlook (Revenue, USD Million, 2021-2033)
- Gene Therapy
- Plasmid DNA (pDNA)
- Viral Vectors
- Non-viral Gene Delivery Systems
- Others
- RNA-based Therapies
- Messenger RNA (mRNA)
- Small Interfering RNA (siRNA)
- Antisense Oligonucleotides (ASO)
- Others
- Gene Therapy
- Global Nucleic Acid Therapeutics Contract Manufacturing Service Outlook (Revenue, USD Million, 2021-2033)
- Process Development and Optimization
- GMP Manufacturing
- Analytical and Quality Control Service
- Fill Finish Contract Manufacturing
- Regulatory Support
- Others
- Global Nucleic Acid Therapeutics Contract Manufacturing Application Outlook (Revenue, USD Million, 2021-2033)
- Oncology
- Rare Diseases
- Genetic Disorders
- Infectious Diseases
- Others
- Global Nucleic Acid Therapeutics Contract Manufacturing End Use Outlook (Revenue, USD Million, 2021-2033)
- Large Biopharmaceutical Companies
- Medium Biopharmaceutical Companies
- Small Biopharmaceutical Companies
- Others
Reasons to subscribe to Global nucleic acid therapeutics contract manufacturing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global nucleic acid therapeutics contract manufacturing market databook
-
Our clientele includes a mix of nucleic acid therapeutics contract manufacturing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global nucleic acid therapeutics contract manufacturing market , including forecasts for subscribers. This global databook contains high-level insights into Global nucleic acid therapeutics contract manufacturing market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Global nucleic acid therapeutics contract manufacturing market size, by regions, 2021-2033 (US$M)
Top 10 countries: Nucleic acid therapeutics contract manufacturing market size, 2024 (US$M)
Global nucleic acid therapeutics contract manufacturing market share, by type, 2024 & 2033 (%, US$M)
Nucleic acid therapeutics contract manufacturing market: Opportunity assessment by country
Global nucleic acid therapeutics contract manufacturing market, by region, 2024 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
